Obesity Treatment-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Obesity Treatment-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Obesity Treatment industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Obesity Treatment 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Obesity Treatment worldwide and market share by regions, with company and product introduction, position in the Obesity Treatment market
Market status and development trend of Obesity Treatment by types and applications
Cost and profit status of Obesity Treatment, and marketing status
Market growth drivers and challenges
The report segments the global Obesity Treatment market as:
Global Obesity Treatment Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Obesity Treatment Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Surgical & Implant Devices
Medication Therapy
Dietary
Other
Global Obesity Treatment Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Children
Adults
Global Obesity Treatment Market: Manufacturers Segment Analysis (Company and Product introduction, Obesity Treatment Sales Volume, Revenue, Price and Gross Margin):
NutriSystem, Inc. (U.S.)
Kellogg Company (U.S.)
Ethicon, Inc. (U.S.)
Medtronic (U.S.)
F. Hoffmann-La Roche (Switzerland)
Atkins Nutritionals, Inc. (U.S.)
Herbalife Ltd. (U.S.)
Covidien plc (U.S.)
Apollo Endosurgery (U.S.)
Amer Sports (Finland)
Johnson Health Technology, Ltd. (Taiwan)
Cybex International (U.S.)
USGI Medical (U.S.)
Olympus Corporation (Japan)
Brunswick Corporation (U.S.)
Technogym SpA (Italy)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Obesity Treatment-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Obesity Treatment industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Obesity Treatment 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Obesity Treatment worldwide and market share by regions, with company and product introduction, position in the Obesity Treatment market
Market status and development trend of Obesity Treatment by types and applications
Cost and profit status of Obesity Treatment, and marketing status
Market growth drivers and challenges
The report segments the global Obesity Treatment market as:
Global Obesity Treatment Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Obesity Treatment Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Surgical & Implant Devices
Medication Therapy
Dietary
Other
Global Obesity Treatment Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Children
Adults
Global Obesity Treatment Market: Manufacturers Segment Analysis (Company and Product introduction, Obesity Treatment Sales Volume, Revenue, Price and Gross Margin):
NutriSystem, Inc. (U.S.)
Kellogg Company (U.S.)
Ethicon, Inc. (U.S.)
Medtronic (U.S.)
F. Hoffmann-La Roche (Switzerland)
Atkins Nutritionals, Inc. (U.S.)
Herbalife Ltd. (U.S.)
Covidien plc (U.S.)
Apollo Endosurgery (U.S.)
Amer Sports (Finland)
Johnson Health Technology, Ltd. (Taiwan)
Cybex International (U.S.)
USGI Medical (U.S.)
Olympus Corporation (Japan)
Brunswick Corporation (U.S.)
Technogym SpA (Italy)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF OBESITY TREATMENT
1.1 Definition of Obesity Treatment in This Report
1.2 Commercial Types of Obesity Treatment
1.2.1 Surgical & Implant Devices
1.2.2 Medication Therapy
1.2.3 Dietary
1.2.4 Other
1.3 Downstream Application of Obesity Treatment
1.3.1 Children
1.3.2 Adults
1.4 Development History of Obesity Treatment
1.5 Market Status and Trend of Obesity Treatment 2013-2023
1.5.1 Global Obesity Treatment Market Status and Trend 2013-2023
1.5.2 Regional Obesity Treatment Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Obesity Treatment 2013-2017
2.2 Sales Market of Obesity Treatment by Regions
2.2.1 Sales Volume of Obesity Treatment by Regions
2.2.2 Sales Value of Obesity Treatment by Regions
2.3 Production Market of Obesity Treatment by Regions
2.4 Global Market Forecast of Obesity Treatment 2018-2023
2.4.1 Global Market Forecast of Obesity Treatment 2018-2023
2.4.2 Market Forecast of Obesity Treatment by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Obesity Treatment by Types
3.2 Sales Value of Obesity Treatment by Types
3.3 Market Forecast of Obesity Treatment by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Obesity Treatment by Downstream Industry
4.2 Global Market Forecast of Obesity Treatment by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Obesity Treatment Market Status by Countries
5.1.1 North America Obesity Treatment Sales by Countries (2013-2017)
5.1.2 North America Obesity Treatment Revenue by Countries (2013-2017)
5.1.3 United States Obesity Treatment Market Status (2013-2017)
5.1.4 Canada Obesity Treatment Market Status (2013-2017)
5.1.5 Mexico Obesity Treatment Market Status (2013-2017)
5.2 North America Obesity Treatment Market Status by Manufacturers
5.3 North America Obesity Treatment Market Status by Type (2013-2017)
5.3.1 North America Obesity Treatment Sales by Type (2013-2017)
5.3.2 North America Obesity Treatment Revenue by Type (2013-2017)
5.4 North America Obesity Treatment Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Obesity Treatment Market Status by Countries
6.1.1 Europe Obesity Treatment Sales by Countries (2013-2017)
6.1.2 Europe Obesity Treatment Revenue by Countries (2013-2017)
6.1.3 Germany Obesity Treatment Market Status (2013-2017)
6.1.4 UK Obesity Treatment Market Status (2013-2017)
6.1.5 France Obesity Treatment Market Status (2013-2017)
6.1.6 Italy Obesity Treatment Market Status (2013-2017)
6.1.7 Russia Obesity Treatment Market Status (2013-2017)
6.1.8 Spain Obesity Treatment Market Status (2013-2017)
6.1.9 Benelux Obesity Treatment Market Status (2013-2017)
6.2 Europe Obesity Treatment Market Status by Manufacturers
6.3 Europe Obesity Treatment Market Status by Type (2013-2017)
6.3.1 Europe Obesity Treatment Sales by Type (2013-2017)
6.3.2 Europe Obesity Treatment Revenue by Type (2013-2017)
6.4 Europe Obesity Treatment Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Obesity Treatment Market Status by Countries
7.1.1 Asia Pacific Obesity Treatment Sales by Countries (2013-2017)
7.1.2 Asia Pacific Obesity Treatment Revenue by Countries (2013-2017)
7.1.3 China Obesity Treatment Market Status (2013-2017)
7.1.4 Japan Obesity Treatment Market Status (2013-2017)
7.1.5 India Obesity Treatment Market Status (2013-2017)
7.1.6 Southeast Asia Obesity Treatment Market Status (2013-2017)
7.1.7 Australia Obesity Treatment Market Status (2013-2017)
7.2 Asia Pacific Obesity Treatment Market Status by Manufacturers
7.3 Asia Pacific Obesity Treatment Market Status by Type (2013-2017)
7.3.1 Asia Pacific Obesity Treatment Sales by Type (2013-2017)
7.3.2 Asia Pacific Obesity Treatment Revenue by Type (2013-2017)
7.4 Asia Pacific Obesity Treatment Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Obesity Treatment Market Status by Countries
8.1.1 Latin America Obesity Treatment Sales by Countries (2013-2017)
8.1.2 Latin America Obesity Treatment Revenue by Countries (2013-2017)
8.1.3 Brazil Obesity Treatment Market Status (2013-2017)
8.1.4 Argentina Obesity Treatment Market Status (2013-2017)
8.1.5 Colombia Obesity Treatment Market Status (2013-2017)
8.2 Latin America Obesity Treatment Market Status by Manufacturers
8.3 Latin America Obesity Treatment Market Status by Type (2013-2017)
8.3.1 Latin America Obesity Treatment Sales by Type (2013-2017)
8.3.2 Latin America Obesity Treatment Revenue by Type (2013-2017)
8.4 Latin America Obesity Treatment Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Obesity Treatment Market Status by Countries
9.1.1 Middle East and Africa Obesity Treatment Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Obesity Treatment Revenue by Countries (2013-2017)
9.1.3 Middle East Obesity Treatment Market Status (2013-2017)
9.1.4 Africa Obesity Treatment Market Status (2013-2017)
9.2 Middle East and Africa Obesity Treatment Market Status by Manufacturers
9.3 Middle East and Africa Obesity Treatment Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Obesity Treatment Sales by Type (2013-2017)
9.3.2 Middle East and Africa Obesity Treatment Revenue by Type (2013-2017)
9.4 Middle East and Africa Obesity Treatment Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF OBESITY TREATMENT
10.1 Global Economy Situation and Trend Overview
10.2 Obesity Treatment Downstream Industry Situation and Trend Overview
CHAPTER 11 OBESITY TREATMENT MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Obesity Treatment by Major Manufacturers
11.2 Production Value of Obesity Treatment by Major Manufacturers
11.3 Basic Information of Obesity Treatment by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Obesity Treatment Major Manufacturer
11.3.2 Employees and Revenue Level of Obesity Treatment Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 OBESITY TREATMENT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 NutriSystem, Inc. (U.S.)
12.1.1 Company profile
12.1.2 Representative Obesity Treatment Product
12.1.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of NutriSystem, Inc. (U.S.)
12.2 Kellogg Company (U.S.)
12.2.1 Company profile
12.2.2 Representative Obesity Treatment Product
12.2.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Kellogg Company (U.S.)
12.3 Ethicon, Inc. (U.S.)
12.3.1 Company profile
12.3.2 Representative Obesity Treatment Product
12.3.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Ethicon, Inc. (U.S.)
12.4 Medtronic (U.S.)
12.4.1 Company profile
12.4.2 Representative Obesity Treatment Product
12.4.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Medtronic (U.S.)
12.5 F. Hoffmann-La Roche (Switzerland)
12.5.1 Company profile
12.5.2 Representative Obesity Treatment Product
12.5.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche (Switzerland)
12.6 Atkins Nutritionals, Inc. (U.S.)
12.6.1 Company profile
12.6.2 Representative Obesity Treatment Product
12.6.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Atkins Nutritionals, Inc. (U.S.)
12.7 Herbalife Ltd. (U.S.)
12.7.1 Company profile
12.7.2 Representative Obesity Treatment Product
12.7.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Herbalife Ltd. (U.S.)
12.8 Covidien plc (U.S.)
12.8.1 Company profile
12.8.2 Representative Obesity Treatment Product
12.8.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Covidien plc (U.S.)
12.9 Apollo Endosurgery (U.S.)
12.9.1 Company profile
12.9.2 Representative Obesity Treatment Product
12.9.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Apollo Endosurgery (U.S.)
12.10 Amer Sports (Finland)
12.10.1 Company profile
12.10.2 Representative Obesity Treatment Product
12.10.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Amer Sports (Finland)
12.11 Johnson Health Technology, Ltd. (Taiwan)
12.11.1 Company profile
12.11.2 Representative Obesity Treatment Product
12.11.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Johnson Health Technology, Ltd. (Taiwan)
12.12 Cybex International (U.S.)
12.12.1 Company profile
12.12.2 Representative Obesity Treatment Product
12.12.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Cybex International (U.S.)
12.13 USGI Medical (U.S.)
12.13.1 Company profile
12.13.2 Representative Obesity Treatment Product
12.13.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of USGI Medical (U.S.)
12.14 Olympus Corporation (Japan)
12.14.1 Company profile
12.14.2 Representative Obesity Treatment Product
12.14.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Olympus Corporation (Japan)
12.15 Brunswick Corporation (U.S.)
12.15.1 Company profile
12.15.2 Representative Obesity Treatment Product
12.15.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Brunswick Corporation (U.S.)
12.16 Technogym SpA (Italy)
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OBESITY TREATMENT
13.1 Industry Chain of Obesity Treatment
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF OBESITY TREATMENT
14.1 Cost Structure Analysis of Obesity Treatment
14.2 Raw Materials Cost Analysis of Obesity Treatment
14.3 Labor Cost Analysis of Obesity Treatment
14.4 Manufacturing Expenses Analysis of Obesity Treatment
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Obesity Treatment in This Report
1.2 Commercial Types of Obesity Treatment
1.2.1 Surgical & Implant Devices
1.2.2 Medication Therapy
1.2.3 Dietary
1.2.4 Other
1.3 Downstream Application of Obesity Treatment
1.3.1 Children
1.3.2 Adults
1.4 Development History of Obesity Treatment
1.5 Market Status and Trend of Obesity Treatment 2013-2023
1.5.1 Global Obesity Treatment Market Status and Trend 2013-2023
1.5.2 Regional Obesity Treatment Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Obesity Treatment 2013-2017
2.2 Sales Market of Obesity Treatment by Regions
2.2.1 Sales Volume of Obesity Treatment by Regions
2.2.2 Sales Value of Obesity Treatment by Regions
2.3 Production Market of Obesity Treatment by Regions
2.4 Global Market Forecast of Obesity Treatment 2018-2023
2.4.1 Global Market Forecast of Obesity Treatment 2018-2023
2.4.2 Market Forecast of Obesity Treatment by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Obesity Treatment by Types
3.2 Sales Value of Obesity Treatment by Types
3.3 Market Forecast of Obesity Treatment by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Obesity Treatment by Downstream Industry
4.2 Global Market Forecast of Obesity Treatment by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Obesity Treatment Market Status by Countries
5.1.1 North America Obesity Treatment Sales by Countries (2013-2017)
5.1.2 North America Obesity Treatment Revenue by Countries (2013-2017)
5.1.3 United States Obesity Treatment Market Status (2013-2017)
5.1.4 Canada Obesity Treatment Market Status (2013-2017)
5.1.5 Mexico Obesity Treatment Market Status (2013-2017)
5.2 North America Obesity Treatment Market Status by Manufacturers
5.3 North America Obesity Treatment Market Status by Type (2013-2017)
5.3.1 North America Obesity Treatment Sales by Type (2013-2017)
5.3.2 North America Obesity Treatment Revenue by Type (2013-2017)
5.4 North America Obesity Treatment Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Obesity Treatment Market Status by Countries
6.1.1 Europe Obesity Treatment Sales by Countries (2013-2017)
6.1.2 Europe Obesity Treatment Revenue by Countries (2013-2017)
6.1.3 Germany Obesity Treatment Market Status (2013-2017)
6.1.4 UK Obesity Treatment Market Status (2013-2017)
6.1.5 France Obesity Treatment Market Status (2013-2017)
6.1.6 Italy Obesity Treatment Market Status (2013-2017)
6.1.7 Russia Obesity Treatment Market Status (2013-2017)
6.1.8 Spain Obesity Treatment Market Status (2013-2017)
6.1.9 Benelux Obesity Treatment Market Status (2013-2017)
6.2 Europe Obesity Treatment Market Status by Manufacturers
6.3 Europe Obesity Treatment Market Status by Type (2013-2017)
6.3.1 Europe Obesity Treatment Sales by Type (2013-2017)
6.3.2 Europe Obesity Treatment Revenue by Type (2013-2017)
6.4 Europe Obesity Treatment Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Obesity Treatment Market Status by Countries
7.1.1 Asia Pacific Obesity Treatment Sales by Countries (2013-2017)
7.1.2 Asia Pacific Obesity Treatment Revenue by Countries (2013-2017)
7.1.3 China Obesity Treatment Market Status (2013-2017)
7.1.4 Japan Obesity Treatment Market Status (2013-2017)
7.1.5 India Obesity Treatment Market Status (2013-2017)
7.1.6 Southeast Asia Obesity Treatment Market Status (2013-2017)
7.1.7 Australia Obesity Treatment Market Status (2013-2017)
7.2 Asia Pacific Obesity Treatment Market Status by Manufacturers
7.3 Asia Pacific Obesity Treatment Market Status by Type (2013-2017)
7.3.1 Asia Pacific Obesity Treatment Sales by Type (2013-2017)
7.3.2 Asia Pacific Obesity Treatment Revenue by Type (2013-2017)
7.4 Asia Pacific Obesity Treatment Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Obesity Treatment Market Status by Countries
8.1.1 Latin America Obesity Treatment Sales by Countries (2013-2017)
8.1.2 Latin America Obesity Treatment Revenue by Countries (2013-2017)
8.1.3 Brazil Obesity Treatment Market Status (2013-2017)
8.1.4 Argentina Obesity Treatment Market Status (2013-2017)
8.1.5 Colombia Obesity Treatment Market Status (2013-2017)
8.2 Latin America Obesity Treatment Market Status by Manufacturers
8.3 Latin America Obesity Treatment Market Status by Type (2013-2017)
8.3.1 Latin America Obesity Treatment Sales by Type (2013-2017)
8.3.2 Latin America Obesity Treatment Revenue by Type (2013-2017)
8.4 Latin America Obesity Treatment Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Obesity Treatment Market Status by Countries
9.1.1 Middle East and Africa Obesity Treatment Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Obesity Treatment Revenue by Countries (2013-2017)
9.1.3 Middle East Obesity Treatment Market Status (2013-2017)
9.1.4 Africa Obesity Treatment Market Status (2013-2017)
9.2 Middle East and Africa Obesity Treatment Market Status by Manufacturers
9.3 Middle East and Africa Obesity Treatment Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Obesity Treatment Sales by Type (2013-2017)
9.3.2 Middle East and Africa Obesity Treatment Revenue by Type (2013-2017)
9.4 Middle East and Africa Obesity Treatment Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF OBESITY TREATMENT
10.1 Global Economy Situation and Trend Overview
10.2 Obesity Treatment Downstream Industry Situation and Trend Overview
CHAPTER 11 OBESITY TREATMENT MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Obesity Treatment by Major Manufacturers
11.2 Production Value of Obesity Treatment by Major Manufacturers
11.3 Basic Information of Obesity Treatment by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Obesity Treatment Major Manufacturer
11.3.2 Employees and Revenue Level of Obesity Treatment Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 OBESITY TREATMENT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 NutriSystem, Inc. (U.S.)
12.1.1 Company profile
12.1.2 Representative Obesity Treatment Product
12.1.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of NutriSystem, Inc. (U.S.)
12.2 Kellogg Company (U.S.)
12.2.1 Company profile
12.2.2 Representative Obesity Treatment Product
12.2.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Kellogg Company (U.S.)
12.3 Ethicon, Inc. (U.S.)
12.3.1 Company profile
12.3.2 Representative Obesity Treatment Product
12.3.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Ethicon, Inc. (U.S.)
12.4 Medtronic (U.S.)
12.4.1 Company profile
12.4.2 Representative Obesity Treatment Product
12.4.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Medtronic (U.S.)
12.5 F. Hoffmann-La Roche (Switzerland)
12.5.1 Company profile
12.5.2 Representative Obesity Treatment Product
12.5.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche (Switzerland)
12.6 Atkins Nutritionals, Inc. (U.S.)
12.6.1 Company profile
12.6.2 Representative Obesity Treatment Product
12.6.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Atkins Nutritionals, Inc. (U.S.)
12.7 Herbalife Ltd. (U.S.)
12.7.1 Company profile
12.7.2 Representative Obesity Treatment Product
12.7.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Herbalife Ltd. (U.S.)
12.8 Covidien plc (U.S.)
12.8.1 Company profile
12.8.2 Representative Obesity Treatment Product
12.8.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Covidien plc (U.S.)
12.9 Apollo Endosurgery (U.S.)
12.9.1 Company profile
12.9.2 Representative Obesity Treatment Product
12.9.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Apollo Endosurgery (U.S.)
12.10 Amer Sports (Finland)
12.10.1 Company profile
12.10.2 Representative Obesity Treatment Product
12.10.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Amer Sports (Finland)
12.11 Johnson Health Technology, Ltd. (Taiwan)
12.11.1 Company profile
12.11.2 Representative Obesity Treatment Product
12.11.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Johnson Health Technology, Ltd. (Taiwan)
12.12 Cybex International (U.S.)
12.12.1 Company profile
12.12.2 Representative Obesity Treatment Product
12.12.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Cybex International (U.S.)
12.13 USGI Medical (U.S.)
12.13.1 Company profile
12.13.2 Representative Obesity Treatment Product
12.13.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of USGI Medical (U.S.)
12.14 Olympus Corporation (Japan)
12.14.1 Company profile
12.14.2 Representative Obesity Treatment Product
12.14.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Olympus Corporation (Japan)
12.15 Brunswick Corporation (U.S.)
12.15.1 Company profile
12.15.2 Representative Obesity Treatment Product
12.15.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Brunswick Corporation (U.S.)
12.16 Technogym SpA (Italy)
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OBESITY TREATMENT
13.1 Industry Chain of Obesity Treatment
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF OBESITY TREATMENT
14.1 Cost Structure Analysis of Obesity Treatment
14.2 Raw Materials Cost Analysis of Obesity Treatment
14.3 Labor Cost Analysis of Obesity Treatment
14.4 Manufacturing Expenses Analysis of Obesity Treatment
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
